美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Definium Therapeutics

22.68

+0.22000.98%

盤後：23.000.3200+1.41%19:48 EDT

成交量：212.22萬

成交額：4,774.46萬

市值：22.61億

市盈率：-11.01

高：23.00

開：22.86

低：22.01

收：22.46

52周最高：23.41

52周最低：5.51

股本：9,969.81萬

流通股本：9,373.67萬

量比：1.17

換手率：2.26%

股息：- -

股息率：- -

每股收益(TTM):-2.0600

每股收益(LYR):-2.0600

淨資產收益率：-64.06%

總資產收益率：-28.01%

市淨率：6.80

市盈率(LYR):-11.01

資料載入中...

總覽公司新聞資訊公告

Definium Therapeutics 研發DT120口腔崩解片針對廣泛性焦慮症、重度抑鬱症及其他嚴重腦健康疾病

美國研究綜述-雪佛龍、Littelfuse、派克-漢尼汾

美國研究綜述-雪佛龍、Littelfuse、派克-漢尼汾

Piper Sandler 首予 Definium Therapeutics 增持評級，目標價49美元

Definium Therapeutics現金儲備雄厚：截至2025年底持有4.116億美元現金及投資，預計可支撐運營至2028年

美國研究綜述-Definium Therapeutics、Kenvue、Werner Enterprises

美國研究綜述-Definium Therapeutics、Kenvue、Werner Enterprises

Mind Medicine (Mindmed) Inc.盤中異動早盤股價大漲5.26%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/DFTX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":22.68,"timestamp":1776456000000,"preClose":22.46,"halted":0,"volume":2122197,"hourTrading":{"tag":"盘后","latestPrice":23,"preClose":22.68,"latestTime":"19:48 EDT","volume":29672,"amount":673377.8367,"timestamp":1776469736107,"change":0.32,"changeRate":0.014109,"amplitude":0.029541},"delay":0,"changeRate":0.009795191451469228,"floatShares":93736700,"shares":99698129,"eps":-2.059999,"marketStatus":"休市中","change":0.22,"latestTime":"04-17 16:00:00 EDT","open":22.86,"high":23,"low":22.01,"amount":47744610.868416,"amplitude":0.044078,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.059999,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1776672000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":22.46,"preHourTrading":{"tag":"盘前","latestPrice":22.86,"preClose":22.46,"latestTime":"09:29 EDT","volume":12386,"amount":284117.62346000003,"timestamp":1776432599999,"change":0.4,"changeRate":0.017809,"amplitude":0.022796},"postHourTrading":{"tag":"盘后","latestPrice":23,"preClose":22.68,"latestTime":"19:48 EDT","volume":29672,"amount":673377.8367,"timestamp":1776469736107,"change":0.32,"changeRate":0.014109,"amplitude":0.029541},"volumeRatio":1.173252746083937,"impliedVol":0.737,"impliedVolPercentile":0.1587},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":93736700,"roa":"-28.01%","roe":"-64.06%","lyrEps":-2.059999,"volumeRatio":1.173252746083937,"shares":99698129,"dividePrice":0,"high":23,"amplitude":0.044078,"preClose":22.46,"low":22.01,"week52Low":5.51,"pbRate":"6.80","week52High":23.41,"institutionHeld":0,"latestPrice":22.68,"eps":-2.059999,"divideRate":0,"volume":2122197,"delay":0,"ttmEps":-2.059999,"open":22.86,"prevYearClose":13.39,"prevWeekClose":21.53,"prevMonthClose":18.9,"prevQuarterClose":18.9,"fiveDayClose":21.53,"twentyDayClose":18.66,"sixtyDayClose":17.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"盤後","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":16,"updateTime":1775793600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-04-17","current":-11.009714,"percent":0,"low":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"high":-8.802064,"avg":-10.147898,"sd":0.764076,"marketCap":2239219977},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977}],"updateTime":1776579623977},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1180337716","title":"Definium Therapeutics 研發DT120口腔崩解片 針對廣泛性焦慮症、重度抑鬱症及其他嚴重腦健康疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1180337716","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180337716?lang=zh_tw&edition=fundamental","pubTime":"2026-04-19 07:43","pubTimestamp":1776555796,"startTime":"0","endTime":"0","summary":"Definium Therapeutics公司正在积极推进其核心产品DT120口腔崩解片的研发进程，该药物主要瞄准广泛性焦虑症、重度抑郁症以及其他一系列严重的脑健康疾病的治疗领域。\n这款名为DT120 ODT的创新疗法，展现了公司在精神健康与神经系统疾病治疗方面的前沿探索。其研发策略聚焦于解决当前临床未满足的重大需求，旨在为深受相关疾病困扰的患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626891167","title":"美國研究綜述-雪佛龍、Littelfuse、派克-漢尼汾","url":"https://stock-news.laohu8.com/highlight/detail?id=2626891167","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626891167?lang=zh_tw&edition=fundamental","pubTime":"2026-04-10 15:38","pubTimestamp":1775806733,"startTime":"0","endTime":"0","summary":"美国研究综述-雪佛龙、Littelfuse、派克-汉尼汾路透4月10日 - 华尔街证券分析师周五调整了对雪佛龙、Littelfuse 和派克-汉尼汾等几家美国上市公司的评级和目标价。* Whitestone REIT WSR.N：Alliance Global Partners将目标价从17美元上调至19美元(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nL4T40T0L7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2413666699.HKD","CVX","DOW","LU2089985449.USD","LU2089984988.USD","LU2210149790.SGD","ESAB","OLN","LU1854103824.USD","LU2211814178.USD","LU0057025933.USD","WAB","OSK","BK4231","WSR","WCN","LABX","LU2290526834.HKD","IE00B19Z6F94.USD","ALAB","RSG","LFUS","AIM","HRI","LU0054578231.USD","BK4109","CC","WM","CE","PH","ITW","LU2125910179.SGD","MIDD","ABBV","IE00B2B36J28.USD","LU0792757196.USD","STZ","WLK","TEX","URI","ASRT","DFTX","LU2238339852.HKD","DE","PLNT","LU1983299246.USD","LU1861219969.SGD","SPIR","MSGS","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626167899","title":"美國研究綜述-雪佛龍、Littelfuse、派克-漢尼汾","url":"https://stock-news.laohu8.com/highlight/detail?id=2626167899","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626167899?lang=zh_tw&edition=fundamental","pubTime":"2026-04-10 15:38","pubTimestamp":1775806733,"startTime":"0","endTime":"0","summary":"美国研究综述-雪佛龙、Littelfuse、派克-汉尼汾路透4月10日 - 华尔街证券分析师周五调整了对雪佛龙、Littelfuse 和派克-汉尼汾等几家美国上市公司的评级和目标价。* Whitestone REIT WSR.N：Alliance Global Partners将目标价从17美元上调至19美元(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nL4S40T0L7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEX","LU0612318385.USD","ITW","LU2360106947.USD","ASRT","LU0175139822.USD","BK4161","WLK","LU1496350502.SGD","MIDD","HRI","IE00B19Z4B17.USD","WSR","WM","LU1430594728.SGD","LU0689472784.USD","RSG","AIM","LU0114720955.EUR","LU2237443895.HKD","STZ","OLN","SPIR","SGXZ23171101.USD","LU0070302665.USD","CE","DE","PH","URI","ESAB","ALAB","ABBV","LU0545039389.USD","LU1093756325.SGD","DOW","OSK","WCN","PLNT","LABX","LU0323240290.USD","WAB","LU0205193047.USD","DFTX","IE00BKVL7J92.USD","CVX","LU0058720904.USD","CC","LU0788109394.HKD","LFUS","MSGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100586830","title":"Piper Sandler 首予 Definium Therapeutics 增持評級，目標價49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100586830","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100586830?lang=zh_tw&edition=fundamental","pubTime":"2026-04-10 11:31","pubTimestamp":1775791902,"startTime":"0","endTime":"0","summary":"投资银行 Piper Sandler 宣布，正式开始对生物制药公司 Definium Therapeutics Inc 进行覆盖研究，并给予其“增持”评级。该机构设定了49美元的目标股价，显示出对其未来增长潜力的积极展望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101183436","title":"Definium Therapeutics現金儲備雄厚：截至2025年底持有4.116億美元現金及投資，預計可支撐運營至2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1101183436","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101183436?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 05:45","pubTimestamp":1772142302,"startTime":"0","endTime":"0","summary":"生物制药公司Definium Therapeutics（股票代码：DFTX）宣布，截至2025年12月31日，公司持有的现金、现金等价物及投资总额达到4.116亿美元。这一强劲的财务状况预计将为公司的持续运营提供充足资金，支撑其业务发展直至2028年。\n巨额的资金储备为Definium Therapeutics推进其研发管线提供了坚实保障。公司专注于创新疗法的开发，充足的资金使其能够在不依赖额外融资的情况下，持续投入关键研发项目并拓展临床研究。这一财务优势不仅增强了公司的运营稳定性，也为其长期战略目标的实现奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607798094","title":"美國研究綜述-Definium Therapeutics、Kenvue、Werner Enterprises","url":"https://stock-news.laohu8.com/highlight/detail?id=2607798094","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607798094?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 15:46","pubTimestamp":1769759195,"startTime":"0","endTime":"0","summary":"美国研究综述-Definium Therapeutics、Kenvue、Werner Enterprises路透1月30日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Definium Therapeutics、Kenvue 和 Werner Enterprises。* Definium Therapeutics Inc DFTX.O：杰富瑞给予买入评级 * Kenvue Inc KVUE.N：杰富瑞将其评级从 \"买入 \"下调至 \"持有 * United Rentals Inc URI.N：摩根大通将目标价从1150美元下调至970美元 * Werner Enterprises Inc WERN.O：TD Cowen恢复其持有评级以下是路透周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nL4S3YV0R0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WM","PGR","BFH","APPF","IBM","CAT","BBT","DECK","NSC","AX","ALGM","RMD","AMP","KVUE","APH","DFTX","VIRT","NDAQ","FTNT","ARE","OBK","VLO","TMO","RHI","DOV","SNDR","LHX","LPLA","MA","BX","RCL","EXP","DOW","KLAC","SBUX","OSK","PLXS","TSCO","URI","WERN","CFR","AJG","PH","CRS","CMCSA"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2607309479","title":"美國研究綜述-Definium Therapeutics、Kenvue、Werner Enterprises","url":"https://stock-news.laohu8.com/highlight/detail?id=2607309479","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607309479?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 15:46","pubTimestamp":1769759195,"startTime":"0","endTime":"0","summary":"美国研究综述-Definium Therapeutics、Kenvue、Werner Enterprises路透1月30日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Definium Therapeutics、Kenvue 和 Werner Enterprises。* Definium Therapeutics Inc DFTX.O：杰富瑞给予买入评级 * Kenvue Inc KVUE.N：杰富瑞将其评级从 \"买入 \"下调至 \"持有 * United Rentals Inc URI.N：摩根大通将目标价从1150美元下调至970美元 * Werner Enterprises Inc WERN.O：TD Cowen恢复其持有评级以下是路透周五报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nL4T3YV0R0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BX","RHI","RCL","TSCO","PH","WM","APPF","NSC","AJG","FTNT","VIRT","SNDR","TMO","CMCSA","PLXS","WERN","AX","KVUE","EXP","CRS","LHX","LPLA","BFH","CFR","APH","BBT","ALGM","RMD","OBK","ARE","VLO","AMP","NDAQ","PGR","DECK","SBUX","DOW","HON","ELV","IBM","URI","OSK","DFTX","MA"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2603375356","title":"Mind Medicine (Mindmed) Inc.盤中異動 早盤股價大漲5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603375356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603375356?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 23:36","pubTimestamp":1768318590,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日23时36分，Mind Medicine  Inc.股票出现波动，股价大幅上涨5.26%。Mind Medicine  Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Xtl生物制药、Decoy Therapeutics Inc.、Briacell Therapeutics Corp.涨幅较大，Decoy Therapeutics Inc.、Scisparc Ltd.、Briacell Therapeutics Corp.较为活跃，换手率分别为1296.01%、1150.41%、307.68%，振幅较大的相关个股有Xtl生物制药、Lexaria Bioscience Corp C/Wts 14/01/2026 、Decoy Therapeutics Inc.，振幅分别为93.69%、67.92%、41.72%。Mind Medicine  Inc.公司简介：Mind Medicine Inc. 是一家处于临床后期的生物制药公司，致力于开发用于治疗大脑健康障碍的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011323363097a1a97b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011323363097a1a97b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","MNMD","DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}